Clinical trial
Randomized Trial of Intravenous Pulse Versus Oral Continuous Cyclophosphamide for Induction of Remission in Systemic ANCA-Associated Vasculitides
NCT00430105 is registered in ClinicalTrials.gov with Cambridge University Hospitals NHS Foundation Trust as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Trial of Intravenous Pulse Versus Oral Continuous Cyclophosphamide for Induction of Remission in Systemic ANCA-Associated Vasculitides
- Lead sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- February 28, 1998
- Completion date
- April 30, 2004
- Enrollment
- 160
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anca associated systemic vasculitis, microscopic polyangiitis, wegener's granulomatosis